FDA Approves Video Game Made By Boston Company For Treating ADHD In Kids

BOSTON (AP) — The U.S. Food and Drug Administration has for the first time approved a video game for treating attention deficit hyperactivity disorder in children. The FDA said Monday the game built by Boston-based Akili Interactive Labs can improve attention function. The game, called EndeavorRx, requires a prescription and is designed for children ages 8 to 12 with certain symptoms of ADHD. It’s the first time the FDA has cleared a digital therapy for improving ADHD symptoms, and the first time the agency has ever authorized marketing of a game-based therapy for any condition. Screenshot of EndeavorRx (Photo credit: Business Wire) The FDA says it looked at data from multiple studies in more than 600 children. A video of the game shows a character traveling a racecourse-like path in a hover board. Sensory and motor tasks are designed to help the player improve cognitive functioning. “We’re proud to make history today with FDA’s decision,” Akili CEO Eddie Martucci said in a statement. “We’re using technology to help treat a condition in an entirely new way as we directly target neurological function through medicine that feels like entertainment.” (© Copyright 2020 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed.)
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Boston News Health Syndicated CBSN Boston ADHD Children With ADHD EndeavorRx FDA Source Type: news